In addition, the metabolic changes orchestrated by OPN in VAT [66,67] advance the hypothesis of its role as a key regulator of the inflammatory processes of obesity-induced adipose tissue inflammation [64] and become a possible target for treatment of adipose tissue-associated disorders, such as cardiac and renal diseases [15,17]. This evidence concerns the gene SPP1 and Obesity.